Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus TLF Q1 2026 Earnings Modest Profitability Amid Quiet Quarter PTEN Q1 2026 Earnings Surprise EPS Beat but Shares Fall on Lingering Headwinds EPAC Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher ABSI Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in AI Drug Discovery GFS Q1 2026 Earnings Earnings Beat Expectations on EPS Shares Rise